David L. Dunner, M.D.

Article

Six-Year Perspectives on the Safety and Tolerability of Nefazodone

January 1, 2002

David L. Dunner, Lyle K. Laird, John Zajecka, et al

Original Research

Efficacy and Safety of Mirtazapine in Major Depressive Disorder Patients After SSRI Treatment Failure: An Open-Label Trial

June 1, 2001

Maurizio Fava, David L. Dunner, John H. Greist, et al

Article

Acute and Maintenance Treatment of Chronic Depression

May 1, 2001

David L. Dunner

Article

Acute and Maintenance Treatment of Chronic Depression

May 1, 2001

David L. Dunner

Original Research

Improved Health-Related Quality of Life and Reduced Productivity Loss After Treatment With Bupropion Sustained Release: A Study in Patients With Major Depression

February 1, 2001

David L. Dunner, W. Jacqueline Kwong, Trisha L. Houser, et al

Article

Introduction: New Strategies for Improving the Treatment of Depression

September 30, 2000

David L. Dunner

Book Review

Pharmacotherapy for Mood, Anxiety, and Cognitive Disorders

September 30, 2000

David L. Dunner

Article

Introduction: New Strategies for Improving the Treatment of Depression

September 30, 2000

David L. Dunner

Article

Optimizing Lithium Treatment

July 31, 2000

David L. Dunner

Original Research

Relationship Between Borderline Personality Disorder and Axis I Diagnosis in Severity of Depression and Anxiety

November 30, 1999

Katherine Anne Comtois, Deborah S. Cowley, David L. Dunner, et al

Article

Lithium Carbonate: Maintenance Studies and Consequences of Withdrawal

August 1, 1998

David L. Dunner

Original Research

A Prospective Safety Surveillance Study for Bupropion Sustained-Release in the Treatment of Depression

July 15, 1998

David L. Dunner, Sidney Zisook, Alacia A. Billow, et al

Six-Year Perspectives on the Safety and Tolerability of Nefazodone

Efficacy and Safety of Mirtazapine in Major Depressive Disorder Patients After SSRI Treatment Failure: An Open-Label Trial

Acute and Maintenance Treatment of Chronic Depression

Acute and Maintenance Treatment of Chronic Depression

Improved Health-Related Quality of Life and Reduced Productivity Loss After Treatment With Bupropion Sustained Release: A Study in Patients With Major Depression

Introduction: New Strategies for Improving the Treatment of Depression

Pharmacotherapy for Mood, Anxiety, and Cognitive Disorders

Introduction: New Strategies for Improving the Treatment of Depression

Optimizing Lithium Treatment

Relationship Between Borderline Personality Disorder and Axis I Diagnosis in Severity of Depression and Anxiety

Lithium Carbonate: Maintenance Studies and Consequences of Withdrawal

A Prospective Safety Surveillance Study for Bupropion Sustained-Release in the Treatment of Depression

ELSEWHERE:

FOLLOW US:

David L. Dunner, M.D.

Six-Year Perspectives on the Safety and Tolerability of Nefazodone

Efficacy and Safety of Mirtazapine in Major Depressive Disorder Patients After SSRI Treatment Failure: An Open-Label Trial

Acute and Maintenance Treatment of Chronic Depression

Acute and Maintenance Treatment of Chronic Depression

Improved Health-Related Quality of Life and Reduced Productivity Loss After Treatment With Bupropion Sustained Release: A Study in Patients With Major Depression

Introduction: New Strategies for Improving the Treatment of Depression

Pharmacotherapy for Mood, Anxiety, and Cognitive Disorders

Introduction: New Strategies for Improving the Treatment of Depression

Optimizing Lithium Treatment

Relationship Between Borderline Personality Disorder and Axis I Diagnosis in Severity of Depression and Anxiety

Lithium Carbonate: Maintenance Studies and Consequences of Withdrawal

A Prospective Safety Surveillance Study for Bupropion Sustained-Release in the Treatment of Depression

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles